✦ LIBER ✦

Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphoma

✍ Scribed by Jed A. Katzel; Sanford J. Kempin; Portia Lagmay-Fuentes; William A. Cook; Frederick P. Siegal; Lizette E. Henriquez; Moon H. Lee; David H. Vesole

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 254 KB
Volume: 83
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21290

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hodgkin disease developing in patients i

Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma

✍ Alessandro Re; Salvatore Casari; Chiara Cattaneo; Fabio Facchetti; GianPiero Cad 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Prognostic factors after non-Hodgkin lym

Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus : Aquitaine cohort, France, 1986–1997

✍ Frantz Thiessard; Philippe Morlat; Catherine Marimoutou; Eric Labouyrie; Jean-Ma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## BACKGROUND. The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case m

Concomitant cyclophosphamide, doxorubici

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

✍ Emanuela Vaccher; Michele Spina; Giampiero di Gennaro; Renato Talamini; Guglielm 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Patterns of central nervous system recur

Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma

✍ Jigna Desai; Robin J. Mitnick; David H. Henry; Josefina Llena; Joseph A. Sparano 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

BACKGROUND. Central nervous system involvement is a common manifestation of non-Hodgkin lymphoma (NHL) in human immunodeficiency virus (HIV)-infected individuals. The purpose of this study was to review the frequency and pattern of neurologic manifestation of lymphoma in a cohort of HIV-infected ind

The International Prognostic Index can b

The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus—related systemic non-Hodgkin lymphoma

✍ Giuseppe Rossi; Alessandra Donisi; Salvatore Casari; Alessandro Re; GianPiero Ca 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## BACKGROUND. The International Prognostic Index (IPI) effectively separates aggressive lymphomas into four groups with significantly different responses to therapy and survival. The authors have applied the IPI to evaluate a series of patients with human immunodeficiency virus (HIV) related lymp

Therapy for non-Hodgkin lymphoma in chil

Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: Analysis of 19 patients from the BFM trials

✍ Seidemann, Kathrin; Tiemann, Markus; Henze, G�nter; Sauerbrey, Axel; M�ller, Sus 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Background. Non-Hodgkin lymphomas (NHL) represent an important complication of primary immunodeficiency (ID), posing new therapeutic challenges in this patient population. This study analyzes clinical data and therapy results of pediatric patients with primary ID and NHL in three consecutive NHL-BFM